{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:26:26Z","timestamp":1789593986624,"version":"build-2803163510"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Pulmonary edema due to vascular endothelial injury in donor lungs reduces organ utilization and exacerbates ischemia\/reperfusion injury, resulting in poor posttransplant outcomes. Sphingosine-1-phosphate (S1P) improves vascular integrity through S1P receptor 1 (S1PR1) signaling. This study assessed whether S1PR1 agonism during ex vivo lung perfusion (EVLP) reduces vascular permeability and edema formation in human donor lungs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>S1PR1 agonist CYM5442 was administered to human donor lungs declined for transplant, during 6\u2009h of EVLP, using a paired split-lung model with one lung treated and the other acting as an internal control. Lung physiology, organ weight, vascular endothelial permeability to Evan\u2019s blue dye, and direCt Lung Ultrasound Evaluation score for lung water were assessed. Sequential perfusate and tissue samples were collected to evaluate gene and protein expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      During EVLP (n\u2005=\u20057 paired sets), CYM5442 reduced Evan\u2019s blue accumulation in bronchoalveolar lavage (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.0260) and tissue (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.0476). Increases in lung weight were ameliorated and direCt Lung Ultrasound Evaluation scores reduced in the CYM5442-treated group post-EVLP (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.0135 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.0482, respectively), leading to reduced pulmonary artery and peak airway pressures (interaction\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.0038 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.0001). CYM5442 maintained vascular endothelial cadherin expression and reduced interleukin-6 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.0130, 360\u2009min), interleukin-1 beta (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.0214, 240\u2009min), and soluble intercellular adhesion molecule-1 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.0067, 360\u2009min) release compared with untreated during EVLP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Agonism of S1PR1 during EVLP ameliorates pulmonary vascular leak and may be used to reduce the risk of edema formation in donor lungs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005793","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:00:20Z","timestamp":1783526420000},"page":"e1815-e1829","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Targeting Sphingosine-1-Phosphate Receptor 1 Protects Pulmonary Vascular Endothelial Integrity During Human Ex Vivo Lung Perfusion"],"prefix":"10.1097","volume":"110","author":[{"given":"Jenny","family":"Gilmour","sequence":"first","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J. S.","family":"Chilvers","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom."},{"name":"Institute of Transplantation, Newcastle Upon Tyne Hospitals, National Health Service Foundation Trust, Freeman Hospital, Newcastle Upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Yun","family":"Pang","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbie E.","family":"Hankins","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neve E.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marnie L.","family":"Brown","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Bates","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Scott","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dark","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Fisher","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom."},{"name":"Institute of Transplantation, Newcastle Upon Tyne Hospitals, National Health Service Foundation Trust, Freeman Hospital, Newcastle Upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simi","family":"Ali","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences, Newcastle University Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"R1-20260824","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1056\/NEJMra2401039","article-title":"Lung transplantation.","volume":"391","author":"Christie","year":"2024","journal-title":"N Engl J Med"},{"key":"R2-20260824","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MOT.0000000000001065","article-title":"Primary graft dysfunction after lung transplantation.","volume":"28","author":"Hunt","year":"2023","journal-title":"Curr Opin Organ Transplant"},{"key":"R3-20260824","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1164\/ajrccm.163.1.2005093","article-title":"Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation.","volume":"163","author":"Fisher","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20260824","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3390\/cells10061417","article-title":"Lung transplantation, pulmonary endothelial inflammation, and ex-situ lung perfusion: a review.","volume":"10","author":"Forgie","year":"2021","journal-title":"Cells"},{"key":"R5-20260824","doi-asserted-by":"crossref","first-page":"100091","DOI":"10.1016\/j.jhlto.2024.100091","article-title":"A novel modified Steen solution limits inflammatory processes during ex vivo lung perfusion and improves graft function post-transplantation.","volume":"4","author":"Gilmour","year":"2024","journal-title":"JHLT Open"},{"key":"R6-20260824","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1152\/physrev.00012.2005","article-title":"Signaling mechanisms regulating endothelial permeability.","volume":"86","author":"Mehta","year":"2006","journal-title":"Physiol Rev"},{"key":"R7-20260824","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1017\/S1462399409001112","article-title":"Molecular mechanisms of endothelial hyperpermeability: implications in inflammation.","volume":"11","author":"Kumar","year":"2009","journal-title":"Expert Rev Mol Med"},{"key":"R8-20260824","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ni.2824","article-title":"Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin.","volume":"15","author":"Wessel","year":"2014","journal-title":"Nat Immunol"},{"key":"R9-20260824","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbamem.2007.09.003","article-title":"Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis.","volume":"1778","author":"Wallez","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"R10-20260824","doi-asserted-by":"crossref","first-page":"25602","DOI":"10.1074\/jbc.M109.009894","article-title":"The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species.","volume":"284","author":"Monaghan-Benson","year":"2009","journal-title":"J Biol Chem"},{"key":"R11-20260824","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00109-009-0463-2","article-title":"Regulation of vascular integrity.","volume":"87","author":"Murakami","year":"2009","journal-title":"J Mol Med (Berl)"},{"key":"R12-20260824","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3892\/etm.2022.11364","article-title":"Sufentanil ameliorates oxygen-glucose deprivation\/reoxygenation-induced endothelial barrier dysfunction in HCMECs via the PI3K\/Akt signaling pathway.","volume":"24","author":"Wang","year":"2022","journal-title":"Exp Ther Med"},{"key":"R13-20260824","doi-asserted-by":"crossref","first-page":"569251","DOI":"10.3389\/fphar.2020.569251","article-title":"Inhibition of p38 MAPK mitigates lung ischemia reperfusion injury by reducing blood-air barrier hyperpermeability.","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"Pt 7","key":"R14-20260824","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1242\/jcs.114.7.1343","article-title":"Rho and Rac but not Cdc42 regulate endothelial cell permeability.","volume":"114","author":"W\u00f3jciak-Stothard","year":"2001","journal-title":"J Cell Sci"},{"key":"R15-20260824","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0092-8674(00)81661-X","article-title":"Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate.","volume":"99","author":"Lee","year":"1999","journal-title":"Cell"},{"key":"R16-20260824","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.devcel.2012.08.005","article-title":"The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2.","volume":"23","author":"Gaengel","year":"2012","journal-title":"Dev Cell"},{"key":"R17-20260824","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.devcel.2012.07.015","article-title":"Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development.","volume":"23","author":"Jung","year":"2012","journal-title":"Dev Cell"},{"key":"R18-20260824","first-page":"852","article-title":"Sphingosine-1-phosphate restores endothelial barrier integrity in ovarian hyperstimulation syndrome.","volume":"22","author":"Scotti","year":"2016","journal-title":"Mol Hum Reprod"},{"key":"R19-20260824","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1113\/expphysiol.2014.082149","article-title":"Differential activation of receptors and signal pathways upon stimulation by different doses of sphingosine-1-phosphate in endothelial cells.","volume":"100","author":"Li","year":"2015","journal-title":"Exp Physiol"},{"issue":"Pt 12","key":"R20-20260824","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1242\/jcs.115.12.2475","article-title":"Distinct signals via Rho GTPases and Src drive shape changes by thrombin and sphingosine-1-phosphate in endothelial cells.","volume":"115","author":"Vouret-Craviari","year":"2002","journal-title":"J Cell Sci"},{"key":"R21-20260824","doi-asserted-by":"crossref","first-page":"H1753","DOI":"10.1152\/ajpheart.00946.2010","article-title":"S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart.","volume":"300","author":"Bandhuvula","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R22-20260824","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvw004","article-title":"Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.","volume":"109","author":"Morel","year":"2016","journal-title":"Cardiovasc Res"},{"key":"R23-20260824","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1440-1797.2010.01386.x","article-title":"Sphingosine-1-phosphate reduces hepatic ischaemia\/reperfusion-induced acute kidney injury through attenuation of endothelial injury in mice.","volume":"16","author":"Lee","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"R24-20260824","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jss.2017.09.048","article-title":"Sinusoidal protection by sphingosine-1-phosphate receptor 1 agonist in liver ischemia-reperfusion injury.","volume":"222","author":"Ito","year":"2018","journal-title":"J Surg Res"},{"key":"R25-20260824","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/STROKEAHA.109.568899","article-title":"Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.","volume":"41","author":"Hasegawa","year":"2010","journal-title":"Stroke"},{"key":"R26-20260824","doi-asserted-by":"crossref","first-page":"F1516","DOI":"10.1152\/ajprenal.00311.2005","article-title":"Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney.","volume":"290","author":"Awad","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"R27-20260824","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1681\/ASN.2015080922","article-title":"Endothelial sphingosine 1\u2011phosphate receptor\u20111 mediates protection and recovery from acute kidney injury.","volume":"27","author":"Perry","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R28-20260824","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1681\/ASN.2011050503","article-title":"Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury.","volume":"23","author":"Park","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R29-20260824","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1600-6143.2006.01710.x","article-title":"Sphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation.","volume":"7","author":"Okazaki","year":"2007","journal-title":"Am J Transplant"},{"key":"R30-20260824","doi-asserted-by":"crossref","first-page":"L1245","DOI":"10.1152\/ajplung.00302.2014","article-title":"Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.","volume":"308","author":"Stone","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R31-20260824","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jtcvs.2018.02.090","article-title":"Increasing circulating sphingosine-1-phosphate attenuates lung injury during ex vivo lung perfusion.","volume":"156","author":"Mehaffey","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R32-20260824","doi-asserted-by":"crossref","first-page":"12573","DOI":"10.3389\/ti.2024.12573","article-title":"A split-lung ex vivo perfusion model for time- and cost-effective evaluation of therapeutic interventions to the human donor lung.","volume":"37","author":"Chilvers","year":"2024","journal-title":"Transpl Int"},{"key":"R33-20260824","doi-asserted-by":"crossref","first-page":"e98546","DOI":"10.1172\/jci.insight.98546","article-title":"Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury.","volume":"3","author":"Shaver","year":"2018","journal-title":"JCI Insight"},{"key":"R34-20260824","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.healun.2019.03.005","article-title":"DireCt Lung Ultrasound Evaluation (CLUE): a novel technique for monitoring extravascular lung water in donor lungs.","volume":"38","author":"Ayyat","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R35-20260824","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.healun.2020.07.013","article-title":"A CLUE for better assessment of donor lungs: novel technique in clinical ex vivo lung perfusion.","volume":"39","author":"Ayyat","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R36-20260824","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.onc.1209855","article-title":"Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.","volume":"26","author":"Wallez","year":"2007","journal-title":"Oncogene"},{"key":"R37-20260824","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/ncb1486","article-title":"VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin.","volume":"8","author":"Gavard","year":"2006","journal-title":"Nat Cell Biol"},{"issue":"Pt 13","key":"R38-20260824","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1242\/jcs.111.13.1853","article-title":"Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells.","volume":"111","author":"Esser","year":"1998","journal-title":"J Cell Sci"},{"key":"R39-20260824","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.athoracsur.2016.01.040","article-title":"Vascular endothelial-cadherin expression after reperfusion correlates with lung injury in rat lung transplantation.","volume":"101","author":"Tanaka","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"R40-20260824","doi-asserted-by":"crossref","first-page":"e24600","DOI":"10.1016\/j.heliyon.2024.e24600","article-title":"Cardiac endothelial ischemia\/reperfusion injury-derived protein damage-associated molecular patterns disrupt the integrity of the endothelial barrier.","volume":"10","author":"Kumphune","year":"2024","journal-title":"Heliyon"},{"key":"R41-20260824","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1096\/fj.201701255R","article-title":"Influence of ex vivo perfusion on the biomolecular profile of rat lungs.","volume":"32","author":"Lonati","year":"2018","journal-title":"FASEB J"},{"key":"R42-20260824","doi-asserted-by":"crossref","first-page":"e682","DOI":"10.1097\/TXD.0000000000001141","article-title":"Ex vivo perfusion with methylprednisolone attenuates brain death-induced lung injury in rats.","volume":"7","author":"van Zanden","year":"2021","journal-title":"Transplant Direct"},{"key":"R43-20260824","doi-asserted-by":"crossref","first-page":"e14570","DOI":"10.1111\/ctr.14570","article-title":"Transcriptional analysis identifies potential novel biomarkers associated with successful ex-vivo perfusion of human donor lungs.","volume":"36","author":"Ferdinand","year":"2022","journal-title":"Clin Transplant"},{"key":"R44-20260824","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/glia.23272","article-title":"Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.","volume":"66","author":"Kim","year":"2018","journal-title":"Glia"},{"key":"R45-20260824","doi-asserted-by":"crossref","first-page":"e0175188","DOI":"10.1371\/journal.pone.0175188","article-title":"Sphingosine 1-phosphate receptor 1 (S1PR1) agonist CYM5442 inhibits expression of intracellular adhesion molecule 1 (ICAM1) in endothelial cells infected with influenza A viruses.","volume":"12","author":"Jiang","year":"2017","journal-title":"PLoS One"},{"key":"R46-20260824","doi-asserted-by":"crossref","first-page":"10272","DOI":"10.1074\/jbc.270.17.10272","article-title":"Involvement of a pertussis toxin-sensitive G protein in the mitogenic signaling pathways of sphingosine 1-phosphate.","volume":"270","author":"Goodemote","year":"1995","journal-title":"J Biol Chem"},{"key":"R47-20260824","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/cmi.2014.59","article-title":"The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment.","volume":"12","author":"Cheng","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"R48-20260824","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.40558","article-title":"Sphingosine 1-phosphate receptor 1 signaling maintains endothelial cell barrier function and protects against immune complex-induced vascular injury.","volume":"70","author":"Burg","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R49-20260824","doi-asserted-by":"crossref","first-page":"eaax8050","DOI":"10.1126\/scisignal.aax8050","article-title":"A G protein biased S1P agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers.","volume":"13","author":"Poirier","year":"2020","journal-title":"Sci Signaling"},{"key":"R50-20260824","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/bcp.14632","article-title":"Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial.","volume":"87","author":"Bergougnan","year":"2021","journal-title":"Br J Clin Pharmacol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:12:46Z","timestamp":1787577166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005793","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]}}}